Free Trial

Stevanato Group S.p.A. (NYSE:STVN) Shares Bought by LPL Financial LLC

Stevanato Group logo with Medical background

LPL Financial LLC grew its holdings in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 24.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 85,721 shares of the company's stock after buying an additional 16,915 shares during the quarter. LPL Financial LLC's holdings in Stevanato Group were worth $1,940,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the business. AMI Asset Management Corp purchased a new stake in Stevanato Group during the 4th quarter worth $1,089,000. SG Americas Securities LLC grew its stake in shares of Stevanato Group by 18.2% in the fourth quarter. SG Americas Securities LLC now owns 15,546 shares of the company's stock valued at $339,000 after buying an additional 2,389 shares in the last quarter. Jennison Associates LLC purchased a new stake in shares of Stevanato Group during the 4th quarter valued at about $20,239,000. Conestoga Capital Advisors LLC lifted its position in Stevanato Group by 5.3% during the 4th quarter. Conestoga Capital Advisors LLC now owns 8,082,996 shares of the company's stock worth $176,128,000 after acquiring an additional 407,086 shares in the last quarter. Finally, Truist Financial Corp boosted its holdings in Stevanato Group by 4.2% in the 4th quarter. Truist Financial Corp now owns 26,900 shares of the company's stock worth $586,000 after acquiring an additional 1,073 shares during the period.

Analyst Ratings Changes

A number of analysts have recently issued reports on STVN shares. UBS Group dropped their price objective on shares of Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a research note on Friday, March 7th. William Blair reaffirmed an "outperform" rating on shares of Stevanato Group in a research note on Friday, March 7th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of €25.70 ($29.38).

Read Our Latest Research Report on STVN

Stevanato Group Stock Down 0.9 %

Shares of NYSE:STVN traded down €0.20 ($0.23) during midday trading on Friday, reaching €21.88 ($25.01). The company had a trading volume of 349,200 shares, compared to its average volume of 353,229. The stock has a market capitalization of $6.63 billion, a P/E ratio of 46.55, a PEG ratio of 7.18 and a beta of 0.52. The stock's fifty day moving average price is €20.56 and its 200-day moving average price is €20.68. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. Stevanato Group S.p.A. has a one year low of €16.56 ($18.93) and a one year high of €29.11 ($33.28).

Stevanato Group (NYSE:STVN - Get Free Report) last issued its earnings results on Thursday, March 6th. The company reported €0.20 ($0.23) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of €0.20 ($0.23). The business had revenue of €352.68 million for the quarter, compared to analyst estimates of €346.26 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. Equities research analysts expect that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.

About Stevanato Group

(Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Read More

Institutional Ownership by Quarter for Stevanato Group (NYSE:STVN)

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines